VISCOSUPPLEMENTATION MARKET SIZE & SHARE ANALYSIS - GROWTH TRENDS & FORECASTS (2023 - 2028)
Viscosupplementation Market Analysis:
The viscosupplementation market is anticipated to experience a compound annual growth rate (CAGR) of 5.8% during the forecast period spanning from 2022 to 2027. The advent of the COVID-19 pandemic has had a significant impact on the viscosupplementation market, as hospital and ambulatory surgical center visits have declined due to lockdown restrictions imposed by various governments worldwide. As a result of these restrictions, non-emergency procedures have been halted in hospitals, which has adversely affected patients’ lives. For example, a study published in the Clinical Pharmacology and Therapeutics Journal in May 2020 by Enrico Ragni et al. revealed that the presence of osteoarthritis-related concomitant disorders is expected to initiate life-threatening risks for osteoarthritis patients in the event of SARS-CoV2 viral infection. This has prompted clinicians and orthopedists to carefully evaluate osteoarthritis patients, not only for symptom management but also for comorbidities that may arise as a result of osteoarthritis treatment during the COVID-19 pandemic. Consequently, the market under investigation is projected to be impacted during the pandemic era. However, with the resumption of procedures, increased hospital visits, and the easing of COVID-19 restrictions, the market is expected to regain its potential over the period.
Several factors are driving market growth, including the rising patient pool suffering from osteoarthritis and the increasing introduction of advanced and combination products. For instance, according to an article published by the Centers for Disease Control and Prevention in April 2020, titled “Osteoarthritis,” approximately 32.5 million people in the United States are suffering from osteoarthritis. Additionally, 62% of women suffer from osteoarthritis. Similarly, according to an article published by the National Center for Biotechnology Information in January 2021, titled “Prevalence of knee osteoarthritis, its determinants, and impact on the quality of life in elderly persons in rural Ballabgarh, Haryana,” it has been observed that 64.3% of the elderly population is suffering from knee osteoarthritis, and elderly patients with knee osteoarthritis have considerably poorer quality-of-life. Furthermore, obesity is another risk factor contributing to orthopedic conditions. For example, according to an article published by the National Center for Biotechnology Information in 2021, titled “Prevalence of Obesity in India and its Neurological Implications: A Multifactor Analysis of a Nationwide Cross-Sectional Study,” the prevalence rate of obesity in India is found to be 40.3%. Additionally, the highest rate of prevalence is found in South India with 46.51%, and the lowest in East India with 32.96%. Thus, the increasing burden of osteoarthritis in patients is likely to increase the demand for viscosupplementation procedures, which reduce joint pain by increasing the lubrication between them, thereby increasing market growth over the forecast period.
However, regulatory issues and a lack of awareness regarding viscosupplementation are likely to restrain market expansion.
Get the free sample report of the Viscosupplementation Market
Comments
Post a Comment